{"id":279341,"date":"2020-12-21T04:48:31","date_gmt":"2020-12-21T09:48:31","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=279341"},"modified":"2020-12-21T04:48:31","modified_gmt":"2020-12-21T09:48:31","slug":"ph-to-get-30m-doses-of-novavax-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2020\/12\/21\/ph-to-get-30m-doses-of-novavax-covid-19-vaccine\/","title":{"rendered":"PH to get 30M doses of Novavax Covid-19 vaccine"},"content":{"rendered":"<figure id=\"attachment_273160\" aria-describedby=\"caption-attachment-273160\" style=\"width: 415px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/10\/dfa-sec-12-25-e.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-273160\" src=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/10\/dfa-sec-12-25-e.jpg\" alt=\"\" width=\"415\" height=\"260\" srcset=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/10\/dfa-sec-12-25-e.jpg 415w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/10\/dfa-sec-12-25-e-300x188.jpg 300w\" sizes=\"auto, (max-width: 415px) 100vw, 415px\" \/><\/a><figcaption id=\"caption-attachment-273160\" class=\"wp-caption-text\">Foreign Affairs Secretary Teodoro Locsin Jr. (PNA File photo)<\/figcaption><\/figure>\n<p><strong>MANILA<\/strong>\u00a0\u2013 Foreign Affairs Secretary Teodoro Locsin Jr. said Monday the country has been assured of 30 million dosages of the Indian-made Novavax coronavirus disease 2019 (Covid-19) vaccine, which would boost the government&#8217;s efforts to secure vaccine supplies for more than 100 million Filipinos.<\/p>\n<p>In a television interview, Locsin said the Novavax may be expected to be available in July 2021.<\/p>\n<p>\u201cThirty million dosages of the Indian-made Novavax vaccines are assured, possibly with no cash advance. It will be available by July 2021,\u201d he said.<br \/>\n&#8220;The term sheet might be signed before the year ends. The good thing though, remember this is not a rumor, is that this is based on a press release made by Serum Institute of India (SII), the giant manufacturer.\u201d<\/p>\n<p>The SII produces Covavax, Novavax, Astrazeneca AZ 1222, and an anti-cancer drug that can also be used to contain Covid-19.<\/p>\n<p>Through a tripartite agreement the government has signed with the private sector, the country has secured 2.6 million doses of a coronavirus vaccine developed by British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca.<\/p>\n<p>The government also plans to buy 25 million doses of a vaccine from China&#8217;s Sinovac Biotech, which will be delivered in March 2021<\/p>\n<p>Negotiations with Moderna and Arcturus Therapeutics Holdings to secure 4 million to 25 million doses of Covid-19 vaccines will begin next week.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MANILA\u00a0\u2013 Foreign Affairs Secretary Teodoro Locsin Jr. said Monday the country has been assured of 30 million dosages of the &hellip;<\/p>\n","protected":false},"author":44,"featured_media":273160,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,95],"tags":[],"class_list":["post-279341","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news","category-news-ph","mauthors-ma-teresa-montemayor","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/279341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=279341"}],"version-history":[{"count":1,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/279341\/revisions"}],"predecessor-version":[{"id":279342,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/279341\/revisions\/279342"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/273160"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=279341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=279341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=279341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}